The influence of comorbidity on treatment outcome for children and adolescents with anxiety disorders

被引:42
|
作者
Rapee, RM [1 ]
机构
[1] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia
关键词
childhood; adolescent; anxiety disorders; cognitive behaviour therapy; group treatment;
D O I
10.1016/S0005-7967(02)00049-9
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
There have been a growing number of studies showing that cognitive behavioural treatment packages for children with anxiety disorders are highly effective. Clinically, it is often assumed that treatment outcome is less successful, or that treatment needs to be altered when faced with the existence of comorbid conditions. To date, only one study has directly addressed this question in the child anxiety literature. The present study compared the treatment outcome and maintenance following a brief, group program for the reduction of child and adolescent anxiety disorders in anxious children with versus without comorbid disorders. There was no significant difference in response to treatment at the end of the program and few differences at 12-month follow-up. The only indication of an impact of comorbidity was a suggestion that children with a comorbid condition did not do as well at follow-up. However, this result was only shown on some parent-report measures and not on self-report measures. Overall, the results indicate that treatment for child and adolescent anxiety disorders produces broadly comparable results regardless of the existence of comorbid disorders. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 50 条
  • [31] Anxiety As a Predictor of Treatment Outcome in Children and Adolescents with Depression
    Cheung, Amy
    Mayes, Taryn
    Levitt, Anthony
    Schaffer, Ayal
    Michalak, Erin
    Kiss, Alex
    Emslie, Graham
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (03) : 211 - 216
  • [32] Influence of Comorbidity in Cognitive-Behavioral Treatment of Anxiety and Mood Disorders
    Philippe, Jessica
    Provencher, Martin D.
    Belleville, Genevieve
    Busque, Guillaume Foldes
    SANTE MENTALE AU QUEBEC, 2022, 47 (01): : 309 - 331
  • [33] Lifetime comorbidity among anxiety disorders and between anxiety disorders and other mental disorders in adolescents
    Lewinsohn, PM
    Zinbarg, R
    Seeley, JR
    Lewinsohn, M
    Sack, WH
    JOURNAL OF ANXIETY DISORDERS, 1997, 11 (04) : 377 - 394
  • [34] Psychological comorbidity and stress reactivity in children and adolescents with recurrent abdominal pain and anxiety disorders
    Dorn, LD
    Campo, JC
    Thato, S
    Dahl, RE
    Lewin, D
    Chandra, R
    Di Lorenzo, C
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (01): : 66 - 75
  • [35] Anxiety disorders in children and adolescents
    Seva, A
    EUROPEAN JOURNAL OF PSYCHIATRY, 2002, 16 (02): : 122 - 122
  • [36] Anxiety Disorders in Children and Adolescents
    Kowalchuk, Alicia
    Gonzalez, Sandra J.
    Zoorob, Roger J.
    AMERICAN FAMILY PHYSICIAN, 2022, 106 (06) : 657 - 664
  • [37] Anxiety Disorders in Children and Adolescents
    Rockhill, Carol
    Kodish, Ian
    DiBattisto, Caroline
    Macias, Michelle
    Varley, Chris
    Ryan, Sheryl
    CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE, 2010, 40 (04) : 66 - 99
  • [38] Children and adolescents' anxiety disorders
    Denis, H.
    Baghdadli, A.
    ARCHIVES DE PEDIATRIE, 2017, 24 (01): : 87 - 90
  • [39] The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
    Operto, Francesca Felicia
    Matricardi, Sara
    Pastorino, Grazia Maria Giovanna
    Verrotti, Alberto
    Coppola, Giangennaro
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [40] Anxiety disorders in children and adolescents
    Küng, A
    Wieser, E
    Aichhorn, M
    Marksteiner, J
    Aichhorn, W
    NEUROPSYCHIATRIE, 2005, 19 (03) : 83 - 88